This heightened cytotoxicity was accompanied by a significant rise in the release of perforin/granzyme B and the expression of CD107a in anti‐B7‐H3 CAR‐NK‐92MI cells, indicating the potential use of B7‐H3‐specific CAR‐NK cells in adoptive cancer immunotherapy [181]. The gene discussed is CD276; the disease is cancer.